Daptomycin and Alendronate sodium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Daptomycin (daptomycin) and Alendronate sodium (alendronate sodium). Common drug interactions include abdominal mass among females and eosinophilic pneumonia acute among males.
The phase IV clinical study analyzes what interactions people have when they take Daptomycin and Alendronate sodium. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Daptomycin?
Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.
What is Alendronate sodium?
Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.
17 people who take Daptomycin and Alendronate sodium together, and have interactions are studied.

What are the common drug interactions of Daptomycin and Alendronate Sodium, by gender? *:
female:
- Abdominal mass (localized enlargement or swelling in the human abdomen)
- Abdominal pain lower
- Abdominal wall abscess (abdominal wall infection)
- Abscess (pus)
- Chills (felling of cold)
- Colitis ulcerative (inflammation of colon with ulcer)
- Depression
- Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
male:
- Eosinophilic pneumonia acute (eosinophil accumulates in the lung-acute)
- Breath sounds
- C-reactive protein increased
- Eosinophil count increased
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
What are the common drug interactions of Daptomycin and Alendronate Sodium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Abdominal distension
- Abdominal hernia
- Abdominal mass (localized enlargement or swelling in the human abdomen)
- Abdominal pain lower
- Abdominal wall abscess (abdominal wall infection)
- Abscess (pus)
- Activities of daily living impaired
- Asthenia (weakness)
- Chills (felling of cold)
- Colitis ulcerative (inflammation of colon with ulcer)
50-59:
- Abdominal hernia
- Abdominal mass (localized enlargement or swelling in the human abdomen)
- Abdominal pain lower
- Abdominal wall abscess (abdominal wall infection)
- Abscess (pus)
- Chills (felling of cold)
- Colitis ulcerative (inflammation of colon with ulcer)
- Depression
- Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
60+:
- Pyrexia (fever)
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- Eosinophilic pneumonia acute (eosinophil accumulates in the lung-acute)
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Febrile neutropenia (fever with reduced white blood cells)
- Hepatocellular injury (liver injury)
- Hypoxia (low oxygen in tissues)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Septic shock (shock due to blood infection)
What are the existing conditions these people have? *
- Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 8 people, 47.06%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
- Back Pain: 2 people, 11.76%
- Muscle Spasms (muscle contraction): 2 people, 11.76%
- Joint Pain: 2 people, 11.76%
- Enterococcal Infection: 2 people, 11.76%
- Type 2 Diabetes: 1 person, 5.88%
- High Blood Pressure: 1 person, 5.88%
- Adverse Event: 1 person, 5.88%
- Aggression: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Daptomycin and Alendronate sodium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Daptomycin (7,879 reports)
- Alendronate sodium (43,608 reports)
Browse all drug interactions of Daptomycin and Alendronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Daptomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Alendronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Daptomycin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Alendronate sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on daptomycin and alendronate sodium (the active ingredients of Daptomycin and Alendronate sodium, respectively), and Daptomycin and Alendronate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Requip cause Pancreatitis Acute? - 9 seconds ago
- Could Sumatriptan Succinate cause Red Blood Cell Count Decreased? - 17 seconds ago
- Drug interactions of Sitagliptin Phosphate and Ranitidine - 20 seconds ago
- Drug interactions of Esomeprazole Magnesium and Pomalidomide - 47 seconds ago
- Drug interactions of Venlafaxine Hydrochloride and Echinacea - a minute ago
- Could Ginger cause Osteoarthritis? - a minute ago
- Drug interactions of Detrol and Pacerone - a minute ago
- Drug interactions of Cyclosporine and Benadryl - a minute ago
- Drug interactions of Sanctura and Zoloft - a minute ago
- Drug interactions of Toprol-Xl and Fenofibrate - a minute ago